Oasis Petroleum Inc. CHRD
We take great care to ensure that the data presented and summarized in this overview for Oasis Petroleum Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CHRD
View all-
Vanguard Group Inc Valley Forge, PA6.45MShares$826 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.22MShares$796 Million0.02% of portfolio
-
State Street Corp Boston, MA2.49MShares$318 Million0.01% of portfolio
-
Victory Capital Management Inc2.25MShares$287 Million0.3% of portfolio
-
Boston Partners Boston, MA2.07MShares$265 Million0.33% of portfolio
-
Wellington Management Group LLP Boston, MA1.64MShares$209 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.45MShares$186 Million0.05% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.25MShares$159 Million0.39% of portfolio
-
Geode Capital Management, LLC Boston, MA1.16MShares$149 Million0.01% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA1.04MShares$132 Million0.54% of portfolio
Latest Institutional Activity in CHRD
Top Purchases
Top Sells
About CHRD
Chord Energy Corporation operates as an independent exploration and production company. It acquires, exploits, develops, and explores for crude oil, natural gas, and natural gas liquids in the Williston Basin. The company was founded in 2007 and is headquartered in Houston, Texas.
Insider Transactions at CHRD
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 10
2024
|
Douglas E Brooks Director |
SELL
Open market or private sale
|
Direct |
2
-0.01%
|
$286
$143.18 P/Share
|
Sep 10
2024
|
Douglas E Brooks Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3
+0.01%
|
$225
$75.57 P/Share
|
Aug 23
2024
|
Samantha Holroyd Director |
BUY
Open market or private purchase
|
Direct |
500
+3.35%
|
$74,500
$149.51 P/Share
|
Aug 19
2024
|
Hilary A Foulkes Director |
BUY
Grant, award, or other acquisition
|
Direct |
647
+23.01%
|
-
|
Aug 19
2024
|
Jeffrey Wayne Sheets Director |
BUY
Grant, award, or other acquisition
|
Direct |
647
+13.6%
|
-
|
Aug 19
2024
|
Ward Polzin Director |
BUY
Grant, award, or other acquisition
|
Direct |
647
+43.25%
|
-
|
Aug 01
2024
|
Shannon Browning Kinney EVP, CAO, GC & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,274
-9.57%
|
$388,854
$171.66 P/Share
|
May 31
2024
|
Ward Polzin Director |
BUY
Grant, award, or other acquisition
|
Direct |
202
+50.0%
|
-
|
May 31
2024
|
Jeffrey Wayne Sheets Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,463
+50.0%
|
-
|
May 31
2024
|
Hilary A Foulkes Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,519
+50.0%
|
-
|
May 31
2024
|
Ian C Dundas Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,481
+31.25%
|
-
|
May 01
2024
|
Marguerite Woung Chapman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+12.82%
|
-
|
May 01
2024
|
Kevin S Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+5.34%
|
-
|
May 01
2024
|
Anne Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+8.47%
|
-
|
May 01
2024
|
Cynthia Lynn Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+5.03%
|
-
|
May 01
2024
|
Susan M Cunningham Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,426
+10.9%
|
-
|
May 01
2024
|
Samantha Holroyd Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+6.97%
|
-
|
May 01
2024
|
Paul Korus Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+7.63%
|
-
|
May 01
2024
|
Douglas E Brooks Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+3.98%
|
-
|
Apr 15
2024
|
Daniel E Brown President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
55,287
-17.55%
|
$10,228,095
$185.31 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 121K shares |
---|---|
Open market or private purchase | 500 shares |
Exercise of in-the-money or at-the-money derivatives securities | 3 shares |
Open market or private sale | 14.8K shares |
---|---|
Payment of exercise price or tax liability | 124K shares |